Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Clinical, immunological and bacteriological characteristics of H7N9 patients nosocomially co-infected by Acinetobacter Baumannii: a case control study

Fig. 2

The risk factors for H7N9-A. baumannii co-infection. a. The comparison of the manipulation of non-invasive ventilation (NV) and invasive mechanical ventilation (MV) between H7N9-A. baumannii co-infected cases (H7N9 + AB) and H7N9 control patients without bacterial co-infection (H7N9). b. The time from the disease onset to the use of antibiotics (Onset to use) and the total time for the antibiotic use (Use to stop) is compared between H7N9 + AB cases and H7N9 controls. c. The time from the disease onset to the use of glucocorticoid (Onset to use) and the total time for the glucocorticoid use (Use to stop) is compared between H7N9 + AB cases and H7N9 controls. d. The total dosages for glucocorticoid and gamma globulin compared between between H7N9 + AB cases and H7N9 controls

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us